Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q4 2019 · 10-K
Revenue$517.20M$517.20M+5.3% vs Q4 2018 Net Income-$19.20M-$19.20MN/M vs Q4 2018 EPS Diluted-$0.59-$0.59N/M vs Q4 2018 Operating Incomederived$71,800,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
Operating Cash Flowderived$25,400,000−44.2% Free Cash Flowderived$2,000,000−93.8% Margins · derivedOperating margin13.9%+24.4 pt vs Q4 2018
Net margin-3.7%+26.4 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 13, 2020 · 73 d after period end